Carboxypeptidase

Carboxypeptidase syndrome is a rare condition in which certain types of bacteria and viruses activate the body's immune responses. This occurs due to a malfunctioning immune system. Some babies are born with a metabolic disorder that results in elevated levels of enzymes that break down peptides (waste products) from body cells. Children may also experience intestinal autoimmune biliary dysplasia syndrome, which is a consequence of defense against bacteria. Carboxypiperidide syndrome is rarely diagnosed, but it has a significant impact on the health of newborns.

Although in the United States this genetic disease is detected in 34 out of a million newborns, it is not always known about it, since some babies are either not yet born or live under observation in medical institutions of various profiles. At the same time, about 10 thousand people, mostly children, suffer from an unknown disease in the world. However, most disorders can only manifest in newborns, causing the prevalence to hover around 1:200 thousand.

Carboxypeplepeptidizoles can be any change in the development of the infant, but their most common form is recurrent jaundice and coagulopathy in early life. This is due to the fact

Carboxypeptidases (CP) are specific enzymes produced by some viruses and bacteria, as well as cells of higher animals and humans. As a rule, they act as lysines and participate in protein dissimilation reactions, accelerating the breakdown of amino acids involved in protein